One might assume that NXPL would repurchase shares at this level to maintain the $1 price. Earlier this year, Michael G. told me that Chairman Fernandez likes to know about the questions expressed by shareholders. My personal opinion is to gauge the level of discontent. Does anyone know if the executive managers read these posts?
The pharmacy business is a challenging industry. For now, NXPL, needs to trim expenses, including staff, perhaps one employee can wear two hats and hope for OPKO to buy us out for $2 to $3 bucks. We’re at the Alamo making our last stand.
I agree. Pharmacies, are a low margin business and struggle to make a profit. Daily and weekly Bollinger Bands are constricting. (Long term shareholder)
I have invested to much in this company. The client with 26,300 shares on the offer is no where near covering my investment. NXPL lacks ability to grow earnings. I’ve found myself in quite a mess.
More like a crocodile with its long nose. The last time the crocodile opened its mouth was within the first quarter of 2018 and now the same look has re appeared. I'm waiting patiently for the crocodile to open its mouth. (Time=decade, frequency=month, 20 period Bollinger bands) *ps I am not affiliated with RXMD
Someone here might consider calling the live call in show Market Wrap with Joe Ansari @ 1-888-581-4140. He will give a technical view of (rxmd) to a select affluent audience, the radio show begins at 5pm Pacific time. I am unable to make this call at the moment.
Elliott Wave technical analyst Moe Ansari with Market Wrap has a live call in show with a broad reach to mostly affluent listeners. He's located on the west coast and his show commences after the market closes. Someone within this board might consider calling him this afternoon on air and ask for his technical opinion regarding (rxmd). I am unable to make this call myself at the moment.